Albert P Parker - Net Worth and Insider Trading
Albert P Parker Net Worth
The estimated net worth of Albert P Parker is at least $725 dollars as of 2024-11-12. Albert P Parker is the COO of OncoCyte Corp and owns about 250 shares of OncoCyte Corp (OCX) stock worth over $725. Details can be seen in Albert P Parker's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Albert P Parker has not made any transactions after 2020-08-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Albert P Parker
Albert P Parker Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Albert P Parker owns 2 companies in total, including OncoCyte Corp (OCX) , and Zynerba Pharmaceuticals Inc (ZYNE) .
Click here to see the complete history of Albert P Parker’s form 4 insider trades.
Insider Ownership Summary of Albert P Parker
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OCX | OncoCyte Corp | 2020-08-03 | Chief Operating Officer |
| ZYNE | Zynerba Pharmaceuticals Inc | 2023-01-31 | Chief Legal Officer |
Albert P Parker Latest Holdings Summary
Albert P Parker currently owns a total of 1 stock. Albert P Parker owns 250 shares of OncoCyte Corp (OCX) as of August 3, 2020, with a value of $725.
Latest Holdings of Albert P Parker
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| OCX | OncoCyte Corp | 2020-08-03 | 250 | 2.90 | 725 |
Holding Weightings of Albert P Parker
Albert P Parker Form 4 Trading Tracker
According to the SEC Form 4 filings, Albert P Parker has made a total of 1 transactions in OncoCyte Corp (OCX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in OncoCyte Corp is the acquisition of 250 shares on August 3, 2020, which cost Albert P Parker around $6,650.
Insider Trading History of Albert P Parker
- 1
Albert P Parker Trading Performance
GuruFocus tracks the stock performance after each of Albert P Parker's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Albert P Parker is -2.52%. GuruFocus also compares Albert P Parker's trading performance to market benchmark return within the same time period. The performance of stocks bought by Albert P Parker within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Albert P Parker's insider trading performs compared to the benchmark.
Performance of Albert P Parker
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -22.64 | | | | | |
| Relative Return to S&P 500(%) | -27.51 | | | | | |
Albert P Parker Ownership Network
Ownership Network List of Albert P Parker
Ownership Network Relation of Albert P Parker
Albert P Parker Owned Company Details
What does OncoCyte Corp do?
Who are the key executives at OncoCyte Corp?
Albert P Parker is the Chief Operating Officer of OncoCyte Corp. Other key executives at OncoCyte Corp include 10 percent owner Broadwood Partners Lp , Interim CEO Josh Riggs , and other: Former Director John Peter Gutfreund .
OncoCyte Corp (OCX) Insider Trades Summary
Over the past 18 months, Albert P Parker made no insider transaction in OncoCyte Corp (OCX). Other recent insider transactions involving OncoCyte Corp (OCX) include a net purchase of 3,735,339 shares made by Broadwood Partners Lp , a net purchase of 33,898 shares made by Andrew Arno , and a net purchase of 33,670 shares made by .
In summary, during the past 3 months, insiders sold 0 shares of OncoCyte Corp (OCX) in total and bought 1,349,009 shares, with a net purchase of 1,349,009 shares. During the past 18 months, 0 shares of OncoCyte Corp (OCX) were sold and 3,807,797 shares were bought by its insiders, resulting in a net purchase of 3,807,797 shares.
OncoCyte Corp (OCX)'s detailed insider trading history can be found in Insider Trading Tracker table.
OncoCyte Corp Insider Transactions
Albert P Parker Mailing Address
Above is the net worth, insider trading, and ownership report for Albert P Parker. You might contact Albert P Parker via mailing address: C/o Oncocyte Corporation, 1010 Atlantic Avenue, Suite 102, Alameda Ca 94501.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
